154 related articles for article (PubMed ID: 9877240)
21. The use of high-frequency short bipolar pulses in cisplatin electrochemotherapy in vitro.
Scuderi M; Rebersek M; Miklavcic D; Dermol-Cerne J
Radiol Oncol; 2019 Jun; 53(2):194-205. PubMed ID: 31194692
[TBL] [Abstract][Full Text] [Related]
22. Cytotoxicity of different platinum (II) analogues to human tumour cell lines in vitro and murine tumour in vivo alone or combined with electroporation.
Cemazar M; Pipan Z; Grabner S; Bukovec N; Sersa G
Anticancer Res; 2006; 26(3A):1997-2002. PubMed ID: 16827135
[TBL] [Abstract][Full Text] [Related]
23. [Progress in electrochemotherapy].
Yang K; Yue B; Wang Z
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Dec; 21(6):1043-6. PubMed ID: 15646362
[TBL] [Abstract][Full Text] [Related]
24. Electroporation of human microvascular endothelial cells: evidence for an anti-vascular mechanism of electrochemotherapy.
Cemazar M; Parkins CS; Holder AL; Chaplin DJ; Tozer GM; Sersa G
Br J Cancer; 2001 Feb; 84(4):565-70. PubMed ID: 11207055
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant electrochemotherapy with bleomycin and cisplatin combination for canine soft tissue sarcomas: A study of 30 cases.
Spugnini EP; Vincenzi B; Amadio B; Baldi A
Open Vet J; 2019 Apr; 9(1):88-93. PubMed ID: 31086772
[TBL] [Abstract][Full Text] [Related]
26. Inter- and intratumoral disposition of platinum in solid tumors after administration of cisplatin.
Zamboni WC; Gervais AC; Egorin MJ; Schellens JH; Hamburger DR; Delauter BJ; Grim A; Zuhowski EG; Joseph E; Pluim D; Potter DM; Eiseman JL
Clin Cancer Res; 2002 Sep; 8(9):2992-9. PubMed ID: 12231546
[TBL] [Abstract][Full Text] [Related]
27. The antitumor efficiency of combined electrochemotherapy and single dose irradiation on a breast cancer tumor model.
Raeisi E; Aghamiri SM; Bandi A; Rahmatpour N; Firoozabadi SM; Kafi-Abad SA; Mir LM
Radiol Oncol; 2012 Sep; 46(3):226-32. PubMed ID: 23077461
[TBL] [Abstract][Full Text] [Related]
28. Tumor growth inhibited by low-voltage amplitude and 5-kHz frequency electrochemotherapy.
Shankayi Z; Firoozabadi SM
J Membr Biol; 2011 Dec; 244(3):121-8. PubMed ID: 22057904
[TBL] [Abstract][Full Text] [Related]
29. Electrochemotherapy of horses. A preliminary clinical report.
Rols MP; Tamzali Y; Teissié J
Bioelectrochemistry; 2002 Jan; 55(1-2):101-5. PubMed ID: 11786351
[TBL] [Abstract][Full Text] [Related]
30. Antitumor effectiveness of different amounts of electrical charge in Ehrlich and fibrosarcoma Sa-37 tumors.
Ciria HC; Quevedo MS; Cabrales LB; Bruzón RP; Salas MF; Pena OG; González TR; López DS; Flores JM
BMC Cancer; 2004 Nov; 4():87. PubMed ID: 15566572
[TBL] [Abstract][Full Text] [Related]
31. Definition of novel electrochemotherapy parameters and validation of their in vitro and in vivo effectiveness.
Spugnini EP; Melillo A; Quagliuolo L; Boccellino M; Vincenzi B; Pasquali P; Baldi A
J Cell Physiol; 2014 Sep; 229(9):1177-81. PubMed ID: 24403005
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant TNF-α therapy to electrochemotherapy with intravenous cisplatin in murine sarcoma exerts synergistic antitumor effectiveness.
Cemazar M; Todorovic V; Scancar J; Lampreht U; Stimac M; Kamensek U; Kranjc S; Coer A; Sersa G
Radiol Oncol; 2015 Mar; 49(1):32-40. PubMed ID: 25810699
[TBL] [Abstract][Full Text] [Related]
33. Potentiation of effects of anticancer agents by local electric pulses in murine bladder cancer.
Ogihara M; Yamaguchi O
Urol Res; 2000 Dec; 28(6):391-7. PubMed ID: 11221918
[TBL] [Abstract][Full Text] [Related]
34. Metastatic potential of melanoma cells is not affected by electrochemotherapy.
Todorovic V; Sersa G; Mlakar V; Glavac D; Flisar K; Cemazar M
Melanoma Res; 2011 Jun; 21(3):196-205. PubMed ID: 20216102
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and tissue distribution of cisplatin in nude mice: platinum levels and cisplatin-DNA adducts.
Johnsson A; Olsson C; Nygren O; Nilsson M; Seiving B; Cavallin-Stahl E
Cancer Chemother Pharmacol; 1995; 37(1-2):23-31. PubMed ID: 7497593
[TBL] [Abstract][Full Text] [Related]
36. Selective intra-arterial infusion of high-dose cisplatin in patients with advanced head and neck cancer results in high tumor platinum concentrations and cisplatin-DNA adduct formation.
Los G; Blommaert fA; Barton R; Heath DD; den Engelse L; Hanchett C; Vicario D; Weisman R; Robbins KT; Howell SB
Cancer Chemother Pharmacol; 1995; 37(1-2):150-4. PubMed ID: 7497585
[TBL] [Abstract][Full Text] [Related]
37. Electrochemotherapy with cisplatin of cutaneous tumor lesions in breast cancer.
Rebersek M; Cufer T; Cemazar M; Kranjc S; Sersa G
Anticancer Drugs; 2004 Jul; 15(6):593-7. PubMed ID: 15205602
[TBL] [Abstract][Full Text] [Related]
38. Effects of electrochemotherapy on CaSki cells derived from a cervical squamous cell carcinoma.
Yabushita H; Yoshikawa K; Hirata M; Furuya H; Hojyoh T; Fukatsu H; Noguchi M; Nakanishi M
Gynecol Oncol; 1997 May; 65(2):297-303. PubMed ID: 9159341
[TBL] [Abstract][Full Text] [Related]
39. Synergism between propolis and hyperthermal intraperitoneal chemotherapy with cisplatin on ehrlich ascites tumor in mice.
Oršolić N; Car N; Lisičić D; Benković V; Knežević AH; Dikić D; Petrik J
J Pharm Sci; 2013 Dec; 102(12):4395-405. PubMed ID: 24136132
[TBL] [Abstract][Full Text] [Related]
40. Effects of intralesional injection of cisplatin dissolved in urografin and lipiodol on Ehrlich ascites tumor and normal tissues of CD-1 mice.
Landrito JE; Yoshiga K; Sakurai K; Takada K
Cancer Chemother Pharmacol; 1994; 34(4):323-30. PubMed ID: 8033299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
